1. A synergic action of colistin, imipenem, and silver nanoparticles against pandrug-resistant Acinetobacter baumannii isolated from patients
- Author
-
Khaled Nauman, Abdullah N. Al Jurayyan, Meshari A. Almosallam, Salah Alahmedi, Muhammad Zubair Siddiqi, Jamal M. Khaled, Ahmed S. Alobaidi, Naiyf S. Alharbi, and Abeer O. Almazyed
- Subjects
Acinetobacter baumannii ,Male ,medicine.medical_specialty ,Imipenem ,Silver ,medicine.drug_class ,Antibiotics ,Metal Nanoparticles ,Microbial Sensitivity Tests ,Infectious and parasitic diseases ,RC109-216 ,Silver nanoparticle ,Microbiology ,Medical microbiology ,Drug Resistance, Multiple, Bacterial ,Female patient ,medicine ,polycyclic compounds ,Humans ,MIC ,FIC index ,biology ,business.industry ,Colistin ,Significant difference ,Public Health, Environmental and Occupational Health ,Drug Synergism ,General Medicine ,biochemical phenomena, metabolism, and nutrition ,biology.organism_classification ,bacterial infections and mycoses ,Anti-Bacterial Agents ,Synergy ,Infectious Diseases ,bacteria ,Female ,Pandrug-resistant ,Public aspects of medicine ,RA1-1270 ,business ,A. baumannii ,Acinetobacter Infections ,medicine.drug - Abstract
Background: The upgrowth and rapid prevalence of pandrug-resistant Acinetobacter baumannii strains that have a pathogenic activity to cause several infections are of considerable influence on the health of communities worldwide. No infections by these bacterial strains were recorded before 1998, and currently, the numbers are on the rise. Methods: The A. baumannii strains were isolated from male and female patients in Medical Microbiology Department, King Fahd Medical City (KFMC) in Riyadh, Saudi Arabia between 1/1/2020 to 29/12/2020. The statistical analysis was performed base on sex, age, source of samples, and response to commercially available antibiotics. The A. baumannii strains that resisted all the antibiotics including colistin and imipenem were selected for the synergic test. Results: The data showed that 62.28%, 77.07% of 342 A. baumannii strains were isolated from males and patients over 35 years of age. A. baumannii strains (pandrug-A. baumannii) that can resist all tested antibiotics were 8.19%. The major source of the A. baumannii isolates was the respiratory system (>50%). Among all isolates (N = 342), azidothymidine-resistant A. baumannii strains were more than 85%. There is a statistically significant difference (P < 0.05) in the number of colistin-resistant A. baumannii strains isolated from males comparing with the female. The combinations of colistin and silver nanoparticles or imipenem and silver nanoparticles resulted in synergistic action led to reduction of MICs of colistin, imipenem, and silver nanoparticles (more than four-fold reduction). Also, the combinations of colistin and imipenem had high synergistic action. Conclusion: The pandrug-resistant A. baumannii strains may represent a current and future threat that must be fought, and the synergy action of antibiotics and nanoparticles may be one of the available, rapid, and easy strategies to confront this global problem.
- Published
- 2021